Marta Piecychna

807 total citations
18 papers, 458 citations indexed

About

Marta Piecychna is a scholar working on Immunology, Cellular and Molecular Neuroscience and Pharmacology. According to data from OpenAlex, Marta Piecychna has authored 18 papers receiving a total of 458 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Immunology, 6 papers in Cellular and Molecular Neuroscience and 1 paper in Pharmacology. Recurrent topics in Marta Piecychna's work include Macrophage Migration Inhibitory Factor (16 papers), Nuclear Receptors and Signaling (6 papers) and Galectins and Cancer Biology (2 papers). Marta Piecychna is often cited by papers focused on Macrophage Migration Inhibitory Factor (16 papers), Nuclear Receptors and Signaling (6 papers) and Galectins and Cancer Biology (2 papers). Marta Piecychna collaborates with scholars based in United States, Germany and Ireland. Marta Piecychna's co-authors include Richard Bucala, Lin Leng, Heather Allore, Richard Bucala, Albert C. Shaw, Ruth R. Montgomery, Linda K. Bockenstedt, Stephen E. Malawista, Erol Fikrig and Jürgen Bernhagen and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Clinical Investigation and The Journal of Immunology.

In The Last Decade

Marta Piecychna

17 papers receiving 454 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Marta Piecychna United States 11 264 92 59 45 39 18 458
Sally Thomson Australia 8 168 0.6× 103 1.1× 35 0.6× 22 0.5× 11 0.3× 11 527
C. Justin Van De Wiele United States 13 299 1.1× 197 2.1× 26 0.4× 43 1.0× 81 2.1× 19 798
Astrid Starke Switzerland 10 110 0.4× 58 0.6× 18 0.3× 52 1.2× 26 0.7× 12 411
Laura Schembri Italy 14 138 0.5× 139 1.5× 19 0.3× 42 0.9× 42 1.1× 28 445
Hideki Matsumura Japan 12 55 0.2× 61 0.7× 75 1.3× 61 1.4× 25 0.6× 33 404
Simon McHugh United Kingdom 13 98 0.4× 127 1.4× 18 0.3× 23 0.5× 47 1.2× 16 498
Selçuk Daşdemir Türkiye 12 120 0.5× 175 1.9× 22 0.4× 35 0.8× 17 0.4× 24 380
Kashif Asghar Pakistan 11 123 0.5× 128 1.4× 16 0.3× 38 0.8× 27 0.7× 29 479
Dave Martin United States 8 113 0.4× 59 0.6× 11 0.2× 45 1.0× 35 0.9× 9 328
Lin Lü China 14 120 0.5× 123 1.3× 36 0.6× 19 0.4× 71 1.8× 35 494

Countries citing papers authored by Marta Piecychna

Since Specialization
Citations

This map shows the geographic impact of Marta Piecychna's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marta Piecychna with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marta Piecychna more than expected).

Fields of papers citing papers by Marta Piecychna

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Marta Piecychna. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marta Piecychna. The network helps show where Marta Piecychna may publish in the future.

Co-authorship network of co-authors of Marta Piecychna

This figure shows the co-authorship network connecting the top 25 collaborators of Marta Piecychna. A scholar is included among the top collaborators of Marta Piecychna based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Marta Piecychna. Marta Piecychna is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Tran, Thuy, Lais Osmani, Marta Piecychna, et al.. (2025). Improving immunotherapy responses by dual inhibition of macrophage migration inhibitory factor and PD-1. JCI Insight. 10(20).
2.
Li, Jia, Lin Leng, Georgios Pantouris, et al.. (2024). A small-molecule allele-selective transcriptional inhibitor of the MIF immune susceptibility locus. Journal of Biological Chemistry. 300(7). 107443–107443. 2 indexed citations
4.
Huth, Sebastian, Ruth Heise, Yvonne Marquardt, et al.. (2023). Macrophage migration inhibitory factor (MIF) and its homolog D-dopachrome tautomerase (D-DT) are significant promotors of UVB- but not chemically induced non-melanoma skin cancer. Scientific Reports. 13(1). 11611–11611. 6 indexed citations
5.
Kim, Bong‐Sung, Pathricia V. Tilstam, Lin Leng, et al.. (2020). Differential regulation of macrophage activation by the MIF cytokine superfamily members MIF and MIF‐2 in adipose tissue during endotoxemia. The FASEB Journal. 34(3). 4219–4233. 28 indexed citations
6.
Ma, Yina, Veena S. Rao, Xiaohong Wu, et al.. (2019). Cardiomyocyte d-dopachrome tautomerase protects against heart failure. JCI Insight. 4(17). 16 indexed citations
7.
Tilstam, Pathricia V., Wibke Schulte, Thomas Holowka, et al.. (2019). Selective Recruitment of Lethal Pro-inflammatory Macrophages in Sepsis by MIF but not D-DT (MIF-2). The Journal of Immunology. 202(1_Supplement). 51.9–51.9. 1 indexed citations
8.
Doherty, Edward, Marta Piecychna, Lin Leng, & Richard Bucala. (2017). Adoptive transfer of a novel MIF receptor (CD74+) expressing memory T cell subpopulation is sufficient to transfer inflammatory arthritis. The Journal of Immunology. 198(Supplement_1). 156.3–156.3. 3 indexed citations
9.
Djudjaj, Sonja, Ina V. Martin, Eva Miriam Buhl, et al.. (2017). Macrophage Migration Inhibitory Factor Limits Renal Inflammation and Fibrosis by Counteracting Tubular Cell Cycle Arrest. Journal of the American Society of Nephrology. 28(12). 3590–3604. 62 indexed citations
10.
Ochi, Akinobu, Dong Chen, Wibke Schulte, et al.. (2017). MIF-2/D-DT enhances proximal tubular cell regeneration through SLPI- and ATF4-dependent mechanisms. American Journal of Physiology-Renal Physiology. 313(3). F767–F780. 33 indexed citations
11.
Kim, Bong‐Sung, Christian Stoppe, Gerrit Grieb, et al.. (2016). The clinical significance of the MIF homolog d-dopachrome tautomerase (MIF-2) and its circulating receptor (sCD74) in burn. Burns. 42(6). 1265–1276. 17 indexed citations
12.
Bick, Johanna, Lin Leng, Marta Piecychna, et al.. (2014). Preliminary associations between childhood neglect, MIF, and cortisol: Potential pathways to long‐term disease risk. Developmental Psychobiology. 57(1). 131–139. 20 indexed citations
13.
Sauler, Maor, Lin Leng, Mark Trentalange, et al.. (2014). Macrophage migration inhibitory factor deficiency in chronic obstructive pulmonary disease. American Journal of Physiology-Lung Cellular and Molecular Physiology. 306(6). L487–L496. 39 indexed citations
14.
Qi, Dake, Lintao Qu, Xiaoyue Hu, et al.. (2014). The vestigial enzyme D-dopachrome tautomerase protects the heart against ischemic injury. Journal of Clinical Investigation. 124(8). 3540–3550. 53 indexed citations
15.
Das, Rituparna, Lakshman Subrahmanyan, Ivana V. Yang, et al.. (2013). Functional Polymorphisms in the Gene Encoding Macrophage Migration Inhibitory Factor Are Associated With Gram-Negative Bacteremia in Older Adults. The Journal of Infectious Diseases. 209(5). 764–768. 16 indexed citations
16.
Qian, Feng, Xiaomei Wang, Lin Zhang, et al.. (2011). Age‐associated elevation in TLR5 leads to increased inflammatory responses in the elderly. Aging Cell. 11(1). 104–110. 120 indexed citations
17.
Dunne, Dana, Albert C. Shaw, Linda K. Bockenstedt, et al.. (2010). Increased TLR4 Expression and Downstream Cytokine Production in Immunosuppressed Adults Compared to Non-Immunosuppressed Adults. PLoS ONE. 5(6). e11343–e11343. 9 indexed citations
18.
Vakil, Varsha, Marta Piecychna, Jeffrey R. Crawford, et al.. (2009). Gadolinium‐containing magnetic resonance image contrast agent promotes fibrocyte differentiation. Journal of Magnetic Resonance Imaging. 30(6). 1284–1288. 27 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026